Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR1 | P30872 | 4/20 | 0.42 |
| ▸ | SSTR2 | P30874 | 4/20 | 0.42 |
| ▸ | SSTR4 | P31391 | 4/20 | 0.42 |
| ▸ | SSTR3 | P32745 | 4/20 | 0.42 |
| ▸ | SSTR5 | P35346 | 4/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.39 |
| ▸ | CDC25B | P30305 | 4/20 | 0.39 |
| ▸ | TACR1 | P25103 | 3/20 | 0.38 |
| ▸ | SELP | P16109 | 1/20 | 0.36 |
| ▸ | NT5E | P21589 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19682247 | 0.91 | SSTR1 (0.49) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL19682263 | 0.84 | SSTR4 (0.53) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL19682266 | 0.83 | SSTR1 (0.49) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL19828324 | 0.78 | PTPN1 (0.41) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL19682246 | 0.75 | AKT1 (0.32) | — | |
| SCHEMBL19682238 | 0.75 | AKT1 (0.32) | — | |
| SCHEMBL19682267 | 0.75 | GJB2 (0.37) | — | |
| SCHEMBL21016939 | 0.73 | GJB2 (0.48) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL19828810 | 0.73 | GJB2 (0.48) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL19682251 | 0.72 | PTPN1 (0.35) | SSTR1SSTR2SSTR4SSTR3SSTR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170348414-A1 | NOVEL SYNTHETIC ANTICANCER, ANTIFUNGAL, AND ANTIBACTERIAL VACCINES | WAYNE STATE UNIVERSITY (US) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170348414-A1 | NOVEL SYNTHETIC ANTICANCER, ANTIFUNGAL, AND ANTIBACTERIAL VACCINES | ERG28, DDOST, STT3A | SSTR1 3532/4885SSTR2 4048/4885SSTR4 3260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.